Do you want to help shape tomorrow’s healthcare with AI? At Pacmed, we combine technology and humanity to keep healthcare accessible and future-proof. We are a growing AI company with solutions already running in multiple hospitals,
Oncology Diagnostics | Netherlands | Field-based (National role) Drive access to innovative oncology diagnostics We are seeking a Client and Market Development Manager to expand patient access and adoption of innovative oncology diagnostic solutions for the southern
Region to cover: Northern Netherlands Duties and Responsibilities: Accompanying applications (trial order of measurement parameters and products) in the field of non-invasive patient monitoring at the customers site Development and implementation of individual overall solutions for the
Company Description Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and our environment safer, healthier and more sustainable. From the
About the Job As Senior Clinical Lead, Early Clinical & Experimental Therapeutics within our Translational Medicine Unit, youll be at the forefront of oncology drug development—designing and leading early clinical studies that could transform treatment options for patients with solid
Our mission LOGEX is at the forefront of healthcare analytics in Europe, transforming data into actionable insights to address the complex challenge of managing costs while improving clinical outcomes. Headquartered in Amsterdam, LOGEX boasts an international team
Selection procedure reference: EMA/TR/11538 Deadline for applications: 30 September 2026 23:59 CEST The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is
Selection procedure reference: EMA/TR/11543 Deadline for applications: 30 September 2026 23:59 CEST The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is
Are you interested in working with data and analytics to solve problems? Are you interested in bringing your GenAI, ML and NLP expertise to projects? About our Team Data Science Life Sciences is a diverse team
About myTomorrows myTomorrows is a global health tech company dedicated to breaking down barriers for patients seeking treatment options. We strive to enable earlier and better treatment access by bridging the gap between those searching for
For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments
Do you want to help shape tomorrow’s healthcare with AI? At Pacmed, we combine technology and humanity to keep healthcare accessible and future-proof. We are a growing AI company with solutions already running in multiple hospitals,
Do you want to help shape tomorrow’s healthcare with AI? At Pacmed, we combine technology and humanity to keep healthcare accessible and future-proof. We are a growing AI company with solutions already running in multiple hospitals,
Company Description For more than 35 years, we have been developing cutting-edge science and technology to empower biomedical research and personalized medicine. We combine excellence from more than 60 disciplines in natural sciences, engineering, and informatics
About myTomorrows myTomorrows is a global health tech company dedicated to breaking down barriers for patients seeking treatment options. We strive to enable earlier and better treatment access by bridging the gap between those searching for
Job title : Medical Projects Manager Location: Amsterdam, Netherlands (Hybrid) Contract: Permanent Why join us: Shape the future of veterinary care across Norway West Region – Lead high-impact medical projects that improve patient outcomes and strengthen
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors